Equity Transfer AgreementEquity Transfer Agreement • February 8th, 2019 • Cybrdi, Inc. • Biological products, (no disgnostic substances)
Party A and Party B have, in accordance with relevant legislation and regulations, reached an agreement through friendly consultations on matters pertaining to the transfer of 80% equity interest in Shaanxi Chaoying Biotechnology Co., Ltd (the “Target Company”) held by Party A and entered into this contract which shall be binding on both parties.
